Peripheral Blood Dendritic Cell Subsets from Patients with Monoclonal Gammopathies Show an Abnormal Distribution and Are Functionally Impaired
Open Access
- 1 January 2008
- journal article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 13 (1) , 82-92
Abstract
Objectives.The information currently available about dendritic cells (DCs) in patients with different types of monoclonal gammopathy (MG) is limited and frequently controversial. In the present study, we analyzed the ex vivo distribution as well as the phenotypic and functional characteristics of peripheral blood (PB) DCs from different types of MG. Methods.For this purpose, 61 untreated patients in total with MG were analyzed—MG of undetermined significance (MGUS), 29 cases; multiple myeloma (MM), 28 cases; and plasma cell leukemia (PCL), 4 cases—in comparison with a group of 10 healthy controls. Results.Our results show an absolute overall higher number of all subsets of PB DCs in PCL, together with lower numbers of myeloid DCs in MM patients. From a phenotypic point of view, PB DC subsets from all types of MG expressed significantly higher levels of HLA molecules and altered patterns of expression of the CD2, CD11c, CD16, CD22, CD62L, and CD86 molecules, in association with altered patterns of secretion of inflammatory cytokines. Conclusion.In summary, we show the existence of significant abnormalities in the distribution, phenotype, and pattern of secretion of inflammatory cytokines by different subsets of PB DCs from patients with MGs, which could reflect a potentially altered homing of DCs, together with a greater in vivo activation and lower responsiveness of PB DCs, which are already detectable in MGUS patients.Keywords
This publication has 48 references indexed in Scilit:
- Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironmentLeukemia, 2005
- New insights into the pathophysiology of multiple myelomaThe Lancet Oncology, 2003
- Genomic abnormalities in monoclonal gammopathy of undetermined significanceBlood, 2002
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCEHematology/Oncology Clinics of North America, 1999
- Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy, and Cytogenetic CharacteristicsBlood, 1999
- Clinical Features and Outcome of Multiple Myeloma Arising from the Transformation of a Monoclonal Gammapathy of Undertermined SignificanceLeukemia & Lymphoma, 1999
- Multiple Myeloma: Increasing Evidence for a Multistep Transformation ProcessBlood, 1998
- The monoclonal gammopathiesClinical Chemistry, 1994